These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fate of two mast cell tryptases in V3 mastocytosis and normal BALB/c mice undergoing passive systemic anaphylaxis: prolonged retention of exocytosed mMCP-6 in connective tissues, and rapid accumulation of enzymatically active mMCP-7 in the blood. Ghildyal N; Friend DS; Stevens RL; Austen KF; Huang C; Penrose JF; Sali A; Gurish MF J Exp Med; 1996 Sep; 184(3):1061-73. PubMed ID: 9064323 [TBL] [Abstract][Full Text] [Related]
5. Human mast cell tryptase in biology and medicine. Vitte J Mol Immunol; 2015 Jan; 63(1):18-24. PubMed ID: 24793463 [TBL] [Abstract][Full Text] [Related]
6. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. Schwartz LB; Sakai K; Bradford TR; Ren S; Zweiman B; Worobec AS; Metcalfe DD J Clin Invest; 1995 Dec; 96(6):2702-10. PubMed ID: 8675637 [TBL] [Abstract][Full Text] [Related]
7. The mouse mast cell-restricted tetramer-forming tryptases mouse mast cell protease 6 and mouse mast cell protease 7 are critical mediators in inflammatory arthritis. McNeil HP; Shin K; Campbell IK; Wicks IP; Adachi R; Lee DM; Stevens RL Arthritis Rheum; 2008 Aug; 58(8):2338-46. PubMed ID: 18668540 [TBL] [Abstract][Full Text] [Related]
8. The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma. Huang C; Wong GW; Ghildyal N; Gurish MF; Sali A; Matsumoto R; Qiu WT; Stevens RL J Biol Chem; 1997 Dec; 272(50):31885-93. PubMed ID: 9395536 [TBL] [Abstract][Full Text] [Related]
9. Human mast cell tryptase fibrinogenolysis: kinetics, anticoagulation mechanism, and cell adhesion disruption. Thomas VA; Wheeless CJ; Stack MS; Johnson DA Biochemistry; 1998 Feb; 37(8):2291-8. PubMed ID: 9485375 [TBL] [Abstract][Full Text] [Related]
10. Drug allergy in mastocytosis. Bonadonna P; Lombardo C Immunol Allergy Clin North Am; 2014 May; 34(2):397-405. PubMed ID: 24745682 [TBL] [Abstract][Full Text] [Related]
11. Effector cells of anaphylaxis: mast cells and basophils. Schwartz LB Novartis Found Symp; 2004; 257():65-74; discussion 74-9, 98-100, 276-85. PubMed ID: 15025392 [TBL] [Abstract][Full Text] [Related]
13. Pediatric Expression of Mast Cell Activation Disorders. Broesby-Olsen S; Carter M; Kjaer HF; Mortz CG; Møller MB; Kristensen TK; Bindslev-Jensen C; Agertoft L Immunol Allergy Clin North Am; 2018 Aug; 38(3):365-377. PubMed ID: 30007457 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Schwartz LB Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288 [TBL] [Abstract][Full Text] [Related]
15. Mast cell tryptase: a review of its physiology and clinical significance. Payne V; Kam PC Anaesthesia; 2004 Jul; 59(7):695-703. PubMed ID: 15200544 [TBL] [Abstract][Full Text] [Related]
16. Epidemiology, prognosis, and risk factors in mastocytosis. Brockow K Immunol Allergy Clin North Am; 2014 May; 34(2):283-95. PubMed ID: 24745674 [TBL] [Abstract][Full Text] [Related]
17. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis. Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452 [TBL] [Abstract][Full Text] [Related]
18. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond. Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092 [TBL] [Abstract][Full Text] [Related]